Influential hydroxychloroquine study used suspect data from company run by pornographic model and sci-fi author

Published



A study showing that the anti-malaria drug touted by President Trump, hydroxychloroquine, harmed COVID-19 patients is likely based on fabricated data.

An investigation by the Guardian found that the study, published in the Lancet (a prestigious medical journal), relied on data from a company called Surgisphere that appears to be highly suspect. The Lancet released an “expression of concern” about the study during the investigation.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.